Pasithea Therapeutics Corp. (KTTA)
NASDAQ: KTTA · IEX Real-Time Price · USD
7.15
+0.25 (3.62%)
At close: Mar 27, 2024, 4:00 PM
7.29
+0.14 (1.96%)
After-hours: Mar 27, 2024, 4:24 PM EDT

Pasithea Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Year Current20222021
Market Capitalization
81939
Market Cap Growth
--51.55%-
Enterprise Value
-12-14-14
PE Ratio
-0.78-1.35-17.82
PS Ratio
31.5938.582572.20
PB Ratio
0.270.440.75
P/FCF Ratio
-0.80-1.12-12.12
P/OCF Ratio
-0.90-1.29-12.21
EV/Sales Ratio
-27.66-28.39-944.38
EV/EBITDA Ratio
0.431.006.55
EV/EBIT Ratio
0.420.996.55
EV/FCF Ratio
0.420.834.45
Debt / Equity Ratio
0.010.01-
Debt / EBITDA Ratio
-0.02-0.04-
Debt / FCF Ratio
-0.02-0.03-
Quick Ratio
9.5817.62118.42
Current Ratio
10.1618.15119.17
Asset Turnover
0.010.010.00
Interest Coverage
-2469.14-136630.88-4277.58
Return on Equity (ROE)
-44.00%-29.20%-12.60%
Return on Assets (ROA)
-41.10%-28.00%-11.40%
Return on Capital (ROIC)
-55.33%-34.45%-8.77%
Earnings Yield
-210.79%-74.25%-5.61%
FCF Yield
-206.53%-88.98%-8.25%
Buyback Yield / Dilution
5.23%-142.70%-41.29%
Total Shareholder Return
5.23%-142.70%-41.29%
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).